Ishizuka T, Satoh T, Monden T, Shibusawa N, Hashida T, Yamada M, Mori M
First Department of Internal Medicine, Gunma University School of Medicine 3-39-15, Maebashi 371-8511, Japan.
Mol Endocrinol. 2001 Aug;15(8):1329-43. doi: 10.1210/mend.15.8.0680.
The DNA-binding domain of nuclear hormone receptors functions as an interaction interface for other transcription factors. Using the DNA-binding domain of TRbeta1 as bait in the yeast two-hybrid system, we cloned the Tat binding protein-1 that was originally isolated as a protein binding to the human immunodeficiency virus type 1 Tat transactivator. Tat binding protein-1 has subsequently been identified as a member of the ATPase family and a component of the 26S proteasome. Tat binding protein-1 interacted with the DNA-binding domain but not with the ligand binding domain of TR in vivo and in vitro. TR bound to the amino-terminal portion of Tat binding protein-1 that contains a leucine zipper-like structure. In mammalian cells, Tat binding protein-1 potentiated the ligand-dependent transactivation by TRbeta1 and TRalpha1 via thyroid hormone response elements. Both the intact DNA-binding domain and activation function-2 of the TR were required for the transcriptional enhancement in the presence of Tat binding protein-1. Tat binding protein-1 did not augment the transactivation function of the RAR, RXR, PPARgamma, or ER. The intrinsic activation domain in Tat binding protein-1 resided within the carboxyl-terminal conserved ATPase domain, and a mutation of a putative ATP binding motif but not a helicase motif in the carboxyl-terminal conserved ATPase domain abolished the activation function. Tat binding protein-1 synergistically activated the TR-mediated transcription with the steroid receptor coactivator 1, p120, and cAMP response element-binding protein, although Tat binding protein-1 did not directly interact with these coactivators in vitro. In contrast, the N-terminal portion of Tat binding protein-1 directly interacted in vitro and in vivo with the TR-interacting protein 1 possessing an ATPase activity that interacts with the activation function-2 of liganded TR. Collectively, Tat binding protein-1 might function as a novel DNA-binding domain-binding transcriptional coactivator specific for the TR probably in cooperation with other activation function-2-interacting cofactors such as TR-interacting protein 1.
核激素受体的DNA结合结构域作为与其他转录因子相互作用的界面。我们在酵母双杂交系统中以TRβ1的DNA结合结构域为诱饵,克隆了最初作为与人免疫缺陷病毒1型Tat反式激活因子结合的蛋白质而分离得到的Tat结合蛋白-1。Tat结合蛋白-1随后被鉴定为ATP酶家族的成员和26S蛋白酶体的一个组分。Tat结合蛋白-1在体内和体外均与TR的DNA结合结构域相互作用,但不与TR的配体结合结构域相互作用。TR与Tat结合蛋白-1含有亮氨酸拉链样结构的氨基末端部分结合。在哺乳动物细胞中,Tat结合蛋白-1通过甲状腺激素反应元件增强TRβ1和TRα1的配体依赖性反式激活。TR完整的DNA结合结构域和激活功能-2对于在Tat结合蛋白-1存在下的转录增强是必需的。Tat结合蛋白-1不会增强RAR、RXR、PPARγ或ER的反式激活功能。Tat结合蛋白-1的内在激活结构域位于羧基末端保守的ATP酶结构域内,羧基末端保守的ATP酶结构域中一个假定的ATP结合基序而非解旋酶基序的突变消除了激活功能。Tat结合蛋白-1与类固醇受体辅激活因子1、p120和cAMP反应元件结合蛋白协同激活TR介导的转录,尽管Tat结合蛋白-1在体外不直接与这些辅激活因子相互作用。相反,Tat结合蛋白-1的氨基末端部分在体内和体外均与具有ATP酶活性的TR相互作用蛋白1直接相互作用,该蛋白与配体化TR的激活功能-2相互作用。总体而言,Tat结合蛋白-1可能作为一种新型的、特异性针对TR的DNA结合结构域结合转录辅激活因子发挥作用,可能与其他激活功能-2相互作用的辅因子如TR相互作用蛋白1协同作用。